The PLIANT study is fully recruited and the final futility

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
The PLIANT study is fully recruited and the final futility analysis approved

Stockholm, 2014-10-21 08:30 CEST (GLOBE NEWSWIRE) --
All 126 patients have now been included in PledPharma’s colorectal cancer study PLIANT and results are expected by the end of Q1 next year.

The DSMB reports that the third and last futility analysis that included 30 patients, in addition to those 60 patients already analyzed, has been completed and that no negative impact on the anticancer effect of the chemotherapy has been observed.

The analysis covers the first 90 patients in the study who have completed four treatment cycles with the chemotherapy mixture FOLFOX after pretreatment with either PledOx ® or placebo. The approval means that PledOx did not weaken the anticancer effect of FOLFOX and that the PLIANT trial be concluded as planned.

" We have now completed the recruitment for the PLIANT study. In the recent months, the recruitment rate has been high and the last patient needed has been included in Part 2 of the study. In total 165 patients have been randomized and have initiated their treatment in the PLIANT study. These patients have in total received more than 600 doses of PledOx to date. Our plan is to present the overall study results at the end of the first quarter of 2015. The results presented will include the effect of PledOx on FOLFOX induced peripheral neuropathy and other dose-limiting side effects.  One important goal is to demonstrate that PledOx does not negatively impair the anticancer effect. Therefore, it is of particular importance that DSMB announced that no further analysis needs to be carried out on the remaining patients", said CEO Jacques Näsström

About the PLIANT study

The PLIANT-study investigates PledOx’s ability to reduce serious FOLFOX-induced side effects during treatment of colorectal cancer. The primary objective is to evaluate the reduction of adverse events related to a decrease in white blood cells (neutrophils) and sensory nerve disorders (neuropathy). The PLIANT study is divided into two parts with an initial dose-escalation part, in order to determine the correct dose-level, and a randomized part, with the goal to establish PledOx’s effect.

In the randomized part, aiming at roughly 126 patients from approximately 30 centers in Europe and the United States, the patients will be divided into three equal groups to receive either placebo or PledOx in two different doses (2 μmol/kg or 5 μmol/kg). For further details please see www.clinicaltrials.gov

For further information, please contact:

Jacques Näsström, CEO

+46 737 13 09 79

Jacques.nasstrom@pledpharma.se

Michaela Gertz, CFO

+46 709 26 17 75

Michaela.gertz@pledpharma.se

About PledPharma

PledPharma is a Swedish pharmaceutical company that develops new therapies for the treatment of life threatening diseases. The initial objective is to develop a drug, PledOx ® , which reduces severe side-effects associated with chemotherapy. The current market for supportive cancer care is some USD 10 billion. PledPharma also evaluates an existing medicines possibility to reduce the damage that occurs on the heart muscle when patients suffer from acute myocardial infarction. In addition to these projects, the company is also evaluating opportunities of using our technology platform in additional areas where there is a significant unmet medical need. PledPharma has the potential to offer patients valuable and unique treatments for serious life-threatening diseases where there is an opportunity fast registration in the US through "breakthrough therapy" designation. This means that the company has the potential to offer shareholders a good return on their investment. PledPharma (STO:PLED) is listed on NASDAQ OMX First North. Erik Penser Bankaktiebolag is the Certified Adviser. For further information, please visit www.pledpharma.se

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Unilumin's APEC 2026 Showcase Is a Useful Field Test

Updated Category News Views 41

Few sales pitches get stress-tested by a thousand journalists, a major airport, and a leaders' summit all at once. That is the useful part of Unilumin's role as an official sponsor of APEC 2026 in Shenzhen. The company says its LED systems were installed across summit venues, the media center, transportation hubs, and city landmarks as the 33rd APEC Economic Leaders'...

Continue Reading
Paratus on the Move: Seagems JV Under the Microscope

Updated Category News Views 131

What's Cooking with Paratus Energy? Paratus Energy Services Ltd. (ticker: PLSV) just threw us a curveball, announcing a strategic review of its participation in the Seagems joint venture. Now, before you get too jazzed about ticker talk—hold your horses. No one's making any promises about transactions just yet. The decision's still hanging in the balance, even as they...

Continue Reading
MAXHUB's Canon Office Test Puts Hybrid Work on Trial

Updated Category News Views 68

Thirty-nine devices scattered through a new Hong Kong office may not sound earth-shaking, but this is how workplace technology actually earns its keep: not under trade-show lights, but when somebody is late to a meeting in another time zone and the room has to work anyway. MAXHUB and Canon Hong Kong have launched the first officially delivered Co-Create 100 project...

Continue Reading
A Decade of Giving: Light the World Initiative's Impact

Updated Category News Views 118

The Red Kiosk Revolution It's not every day that a church initiative pops up in global conversations, but here we are—ten years into the Light the World initiative by The Church of Jesus Christ of Latter-day Saints. What's interesting is how these little kiosks, like silent ambassadors, have become a staple in 145 spots this holiday season, spanning continents. Each...

Continue Reading
FULC, DSGR and OPCH Deals Draw Fresh Shareholder Scrutiny

Updated Category News Views 64

Three proposed transactions have drawn the kind of legal glare that makes shareholders sit up and check the fine print twice. On November 18, 2026, Halper Sadeh LLC said it was investigating deals involving Fulcrum Therapeutics, Distribution Solutions Group, and Option Care Health for possible federal securities-law violations or fiduciary-duty breaches. That is not a...

Continue Reading
New Flight Charters Puts a Cap on Winter Surprises

Updated Category News Views 175

Ice on a wing is routine; ice on an invoice is where charter customers start muttering. New Flight Charters says it will again absorb de-icing and hangar charges this winter, up to $2,500 per trip, marking the seventh consecutive season for the program. In a business where the headline quote can look tidy and the final bill can arrive wearing muddy boots, that is a...

Continue Reading
Xailient Tops NIST for Real-World AI Face Recognition

Updated Category News Views 87

In a world where bigger ain't always better, Xailient's latest triumph at NIST's face recognition test has set them apart. On November 17, 2026, the U.S. National Institute of Standards and Technology (NIST) crowned Xailient as the leader in face recognition accuracy for on-device AI, leaving 105 others in the dust. This ain't your run-of-the-mill achievement—it shows...

Continue Reading
MetaComp Targets ASEAN's Cross-Border Payment Snarl

Updated Category News Views 30

ASEAN payment plumbing is still a patchwork, and MetaComp is betting that patchwork has finally become painful enough to fix. The Singapore-based payments firm says its StableX Agentic Network has topped 1,000 members and reaches more than 100,000 users in its first year. That is a respectable early footprint, not a victory lap. Cross-border payments are littered with...

Continue Reading
Cavalry’s I-70 Towing Bet Starts With Columbus Base

Updated Category News Views 71

A jackknifed tractor-trailer does not care about a private-equity playbook. It needs the right rig, a trained crew and somebody arriving before a blocked highway turns into an all-day mess. That unglamorous reality is exactly why Southfield Capital’s new Cavalry Fleet Services platform deserves a closer look. Commercial towing is a necessary, hard-edged local business...

Continue Reading
Mike Blyth’s Hall of Fame Honors a Builder’s Legacy

Updated Category News Views 147

Recognition earned in the hangar, not a boardroom Aircraft design has a ruthless way of exposing empty talk, which is why Mike Blyth’s November 11 induction into the EAA Homebuilders Hall of Fame carries real weight. The Experimental Aircraft Association’s honor, presented in the Eagle Hangar at the EAA Aviation Museum in Oshkosh, Wisconsin, recognizes a career built...

Continue Reading

Top 5 Most Recently Viewed Articles

Taiwan Semiconductor Rises as AI Demand Fuels Growth Potential

Updated Category News Views 226

Taiwan Semiconductor's Recent Performance Taiwan Semiconductor Manufacturing Company Ltd (NYSE: TSM) has witnessed impressive trading activity, nearing its 52-week high recently. The surge in stock price can be attributed to the increasing demand for AI technologies, which continues to invigorate the semiconductor industry. Analyst Insights on TSM Buy Rating and Price...

Continue Reading
TENX Plummets 85%: Shareholder Lawsuits Loom

Updated Category News Views 26

When Clinical Trials Go South When a Phase 3 trial misses its mark, you can bet the market's gonna react, and not in the way anyone holding shares of Tenax Therapeutics (NASDAQ:TENX) wanted. Last week, TENX lost a jaw-dropping 84-85% of its value in just one trading session. The culprit? The Phase 3 LEVEL trial of TNX-103 that failed to deliver—not hitting its primary...

Continue Reading
An Unforgettable Evening: Ismael Cala Foundation's Gala

Updated Category News Views 287

A Night of Elegance with the Ismael Cala Foundation A night of elegance, music, and Cuban culture to promote El Vuelo de la Cometa (The Flight of the Kite) An Enchanting Experience in a Tropical Paradise This year, the Ismael Cala Foundation is set to host its remarkable Legacy of Light Gala at the breathtaking Cala Botanic Sanctuary. Under the serene glow of the Full...

Continue Reading
FDCTech, Inc. Pursues Strategic Acquisition of Xoala in Europe

Updated Category News Views 171

FDCTech, Inc. Sets Course for European Market Expansion FDCTech, Inc. is taking a bold step into the European payments sector with the planned acquisition of Xoala, a regulated electronic money institution. This acquisition could reshape FDCTech's operational landscape, paving the way for growth in a market valued at approximately $2 trillion. Strategic Significance of...

Continue Reading
Heineken N.V. Updates on Its Share Buyback Program's Progress

Updated Category News Views 154

Heineken N.V. Provides Insights on Share Buyback Program Heineken N.V. is currently engaging in a share buyback program that reflects its commitment to enhancing shareholder value. Recently, the company disclosed substantial updates regarding transactions executed under the initial tranche of this program. Heineken N.V. (EURONEXT: HEIA; OTCQX: HEINY) announced that it has...

Continue Reading